National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2016 (No. 1) (PB 4 of 2016) (Cth)

PB 4 of 2016

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2016 (No. 1)

National Health Act 1953

I, JULIANNE QUAINE, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 25 January                   2016

JULIANNE QUAINE
First Assistant Secretary (Acting)

Pharmaceutical Benefits Division
Department of Health

___________________________________________________________________________

Amendment determination – Pharmaceutical Benefits – Early Supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2016 (No. 1)

(2)This Instrument may also be cited as PB 4 of 2016.

2          Commencement

This Instrument commences on 1 February 2016.

3          Amendment of PB 120 of 2016

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1        Amendments

1. Schedule 1, after entry for Rotigotine in the form Transdermal patch 9 mg

   insert:

Ruxolitinib	Tablet 5 mg	20	112	5
Ruxolitinib	Tablet 15 mg	20	56	5
Ruxolitinib	Tablet 20 mg	20	56	5